Conclusion: complaint confirmed for the pixie cvr's oozing flow issue.The issue was verified via the customer-provided photos, which also show the pressure relief valve inside the jar.A loose or absent pressure relief valve could have contributed to the blood flow/oozing issue observed.Review of this unit's device history record found no abnormalities or ncmrs initiated during manufacturing that would cause or contribute to the reported event.This unit passed all required inspections and testing during manufacturing.A previous investigation into complaints for the pressure relief valve falling into the pixie cvr, and suggests the following potential root causes: dimensional design of the valve and valve seat, a new injection molding tool qualified in 2018, insertion of the obturator cap during manufacturing and/or use-related manipulation of the cap and valve, use of vavd, and physical shock and/or material property changes during sterilization, shipping, and storage.Root cause is undetermined.Trends for issues with this product are reviewed at quarterly quality meetings.This regulatory report is being submitted as part of a retrospective review and remediation per d00953163 as part of a capa action.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|